Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate

Dialysate Concentrate For Hemodialysis (liquid Or Powder)

Fresenius Medical Care Renal Therapies Group, LLC

The following data is part of a premarket notification filed by Fresenius Medical Care Renal Therapies Group, Llc with the FDA for Citrasate Liquid Acid Concentrate, Naturalyte Liquid Acid Concentrate.

Pre-market Notification Details

Device IDK192017
510k NumberK192017
Device Name:Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate
ClassificationDialysate Concentrate For Hemodialysis (liquid Or Powder)
Applicant Fresenius Medical Care Renal Therapies Group, LLC 920 Winter Street Waltham,  MA  02451
ContactDenise Oppermann
CorrespondentDenise Oppermann
Fresenius Medical Care Renal Therapies Group, LLC 920 Winter Street Waltham,  MA  02451
Product CodeKPO  
CFR Regulation Number876.5820 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2019-07-29
Decision Date2020-04-24

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00840861101887 K192017 000
10840861101709 K192017 000
10840861101693 K192017 000
10840861101686 K192017 000
10840861101679 K192017 000
10840861101662 K192017 000
10840861101655 K192017 000
10840861101648 K192017 000
10840861101631 K192017 000
10840861101624 K192017 000
10840861101716 K192017 000
10840861101723 K192017 000
00840861101870 K192017 000
00840861101863 K192017 000
00840861101856 K192017 000
00840861101849 K192017 000
00840861101832 K192017 000
10840861101808 K192017 000
10840861101754 K192017 000
10840861101747 K192017 000
10840861101730 K192017 000
10840861101617 K192017 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.